Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Yield10 Bioscience Announces Closing of $12.7 Million Public Offering
-
Moleculin Biotech (MBRX) Prices 14.27M Share Common Offering at $4.75/Sh
-
Moleculin Announces Pricing Of $67.8 Million Underwritten Public Offering
-
Ucommune Announces Closing of $20.0 Million Underwritten Public Offering
-
Growth Capital Acquisition Corp. Announces Closing of $172.5 Million Upsized Initial Public Offering and Full Exercise of the Overallotment Option
-
NLS Pharmaceutics Ltd. Announces Closing of $20.0 Million Initial Public Offering
-
Naked Brand Group Closes $50 Million Registered Direct Offering Priced At-The-Market
-
RHK Capital Team Joins Noble Capital Markets
-
RHK Capital Team Joins Noble Capital Markets
-
Yield10 Bioscience, Inc. (YTEN) Prices 1.04M Share Offering at $12.25/Sh
-
Cannabis Cultivators Focus on Developing Stronger THC Blends As Demand Skyrockets
-
MEDIROM Healthcare Technologies Inc. Announces Exercise and Closing of Over-Allotment Option in Initial Public Offering
-
Yield10 Bioscience Announces Pricing of $12.7 Million Public Offering
-
Yield10 Bioscience Announces Proposed Public Offering of Common Stock
-
Growth Capital Acquisition Corp. (GCAC) Prices 15M Unit Upsized IPO at $10/Unit
-
Growth Capital Acquisition Corp. Announces Pricing of Upsized $150 Million Initial Public Offering
-
Ucommune International Ltd. (UK) Prices 4.94M Class A Share Common Offering at $4.05/Sh
-
NLS Pharmaceutics Ltd. (NLSP) Prices 4.82M Share IPO at $4.15/Sh
-
Ucommune Announces Pricing of US$20 Million Underwritten Offering
-
NLS Pharmaceutics Ltd. Announces Pricing of $20.0 Million Initial Public Offering
-
LMF Acquisition Opportunities, Inc. Announces Closing of $103.5 Million Upsized Initial Public Offering, Including Full Exercise of the Overallotment Option
-
Agrify Corporation (AGFY) IPO Opens 30% Higher
-
Agrify Corporation (AGFY) Prices 5.4M Share Upsized IPO at $10/Sh
-
Naked Brand Group Limited (NAKD) Prices 29.415M Share Registered Direct Offering at $1.70/Sh
-
Naked Brand Group Announces Pricing of $50 Million Registered Direct Offering Priced At-The-Market
-
Agrify Corporation Announces Pricing of Upsized $54 Million Initial Public Offering
-
Globus Maritime (GLBS) Announces Pricing of $16.3 Million Registered Direct Offering of Common Shares, Warrants
-
Globus Maritime Limited Announces Pricing of $16.3 Million Registered Direct Offering
-
Biolase (BIOL) PT Raised to $2 at Maxim Group, Following Business Update
-
LMF Acquisition Opportunities, Inc. (LMAO) Prices 9M Unit Upsized IPO at $10/Unit
-
LMF Acquisition Opportunities, Inc. Announces Pricing of Upsized $90 Million Initial Public Offering
-
INOVIO Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
OncoSec Medical Closes $42.0 Million Public Offering of Common Stock
-
Inpixon (INPX) Announces Pricing of $30.0 Million Registered Direct Offering of Common Stock, Warrants
-
Inpixon Announces Pricing of $30.0 Million Registered Direct Offering Priced At-The-Market
-
SVB Financial (SIVB) PT Raised to $600 at Maxim Group; 'Top Bank Pick'
-
Kintara Therapeutics, Inc (KTRA) PT Doubled to $6 at Maxim Group
-
Bionano Genomics Announces Closing of $230 Million Underwritten Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Pre-Open Stock Movers 01/22: (ADMP) (CLII) (SCYX) Higher; (PGEN) (IBM) (GSL) Lower (more...)
-
Bionano Genomics (BNGO) PT Raised to 'Street High' $14 at Maxim Group
-
Oncosec Medical (ONCS) Prices $42 Million Public Offering of Common Stock at $5.45/sh
-
OncoSec Medical Announces Pricing of $42.0 Million Public Offering of Common Stock
-
Maxim Group Assumes Agilysys Inc (AGYS) at Buy
-
Inovio Pharma (INO) Prices 17.7M Share Common Offering at $8.50/Sh
-
INOVIO Announces Pricing of Public Offering of Common Stock
-
Nicolet Bankshares (NCBS) PT Raised to $87 at Maxim Group, Following Earnings
-
BioNano Genomics, Inc. (BNGO) Prices 33.3M Share Common Stock Offering at $6/Each
-
Bionano Genomics Announces Pricing of $200 Million Underwritten Public Offering of Common Stock
-
BioNano Genomics, Inc. (BNGO) to Offer Common Stock
-
Bionano Genomics Announces Proposed Underwritten Public Offering of Common Stock

